Pay in 4 interest-free payments of $6.34 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
The results of this phase 3 clinical trial point to semaglutide as a useful tool to treat MASH with nearly 63% of participants experiencing reduced inflammation and approximately 37% showing less liver scarring
722 Busjahn, A
Marketed under the brand name Zepbound for weight loss, tirzepatide is also approved as Mounjaro for type 2 diabetes management
Kubota T, McTiernan CF, Frye CS, Slawson SE, Lemster BH, Koretsky AP, Demetris AJ, Feldman AM
US$ 26.30
US$ 28.02
US$ 20.43
